BSE - Delayed Quote INR
Novartis India Limited (NOVARTIND.BO)
At close: 3:56 PM GMT+5:30
Research Analysis
Revenue vs. Earnings
Revenue 922.9M
Earnings 257.4M
Analyst Price Targets
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | |
|---|---|
| EPS Est. | -- |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NOVARTIND.BO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.10% |
| Next Qtr. | -- | -- | -- | 8.00% |
| Current Year | -- | -- | -- | 2.30% |
| Next Year | -- | -- | -- | 13.20% |
| Next 5 Years (per annum) | -- | -- | -- | 11.85% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
SUVEN.BO Suven Life Sciences Limited
114.50
-7.40%
JAGSNPHARM.BO Jagsonpal Pharmaceuticals Limited
459.40
-5.56%
LINCOLN.NS Lincoln Pharmaceuticals Limited
644.25
-2.50%
GLS.BO Glenmark Life Sciences Limited
1,045.15
-5.96%
HIKAL.BO Hikal Limited
348.85
-5.88%
APLLTD.BO Alembic Pharmaceuticals Limited
1,090.70
-4.42%
UNICHEMLAB.NS Unichem Laboratories Limited
855.75
+12.90%
ORCHPHARMA.NS Orchid Pharma Limited
1,248.65
-4.90%
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
456.20
-6.38%
EMCURE.NS EMCURE PHARMACEUTICALS L
1,394.70
-4.02%